EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Semaglutide‐Induced Weight Loss Does Not Impair Muscle Function and Improves Endurance Running Capacity in Obese Mice

Petras Minderis, Leonardo Cesanelli, Mazvydas Sviderskis, Tomas Venckunas, Stuart R. Gray, Aivaras Ratkevicius

Journal of Cachexia, Sarcopenia and Muscle · 2026-12 · 17 (6)

DOI: 10.1002/jcsm.70427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 17.11.2026. Verfasst von Petras Minderis und 5 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lietuvos Mokslo Taryba.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Semaglutide, a member of the glucagon‐like peptide‐1 receptor agonists, induces substantial weight loss, primarily through appetite suppression and reduced energy intake. In addition to fat mass reduction, a considerable loss of lean body mass is also observed. How these effects compare to conventional caloric restriction is unclear. The aim of the current study was to compare the effects of semaglutide injections and energy‐matched caloric restriction on skeletal muscle mass, function and exercise capacity.

Methods

An 8‐month‐old high‐fat diet‐induced obese male C57BL/6J mice were pair‐fed ( n = 14), with one receiving semaglutide injections (SEMA; 30 μg/kg/day) and the other undergoing energy‐matched caloric restriction (CR; sham PBS injections) for 28 days. A group of obese mice ( n = 12) continued unrestricted high‐fat feeding and served as controls (CON). Body mass and energy intake were monitored daily. During the final week, exercise capacity was assessed using a progressive treadmill test with oxygen consumption and lactate measurements. At study completion, mice were euthanized, and slow‐ and fast‐twitch muscles (soleus [SOL] and extensor digitorum longus [EDL]) were dissected, weighed and used for ex vivo assessment of mechanical and contractile properties.

Results

Despite similar energy intake, SEMA mice lost more body mass than CR mice (20.9 ± 4.9 vs. 14.8% ± 5.8%, p < 0.01). Both groups exhibited lower SOL muscle mass compared with CON (10.0 ± 0.7 mg; SEMA: 9.1 ± 0.8 mg, p < 0.01; CR: 9.4 ± 0.7 mg, p < 0.05), whereas EDL muscle mass was not significantly different. During the treadmill test, SEMA mice displayed higher relative VO 2 peak (43.4 ± 3.0 mL/min/ kg 0.75 ) compared with CR (40.8 ± 2.6 mL/min/kg 0.75 , p < 0.05) and CON (38.6 ± 2.69 mL/min/kg 0.75 , p < 0.001), together with advantages in running distance and maximal running speed, which were largely attributable to lower body mass. SOL and EDL force, normalized to muscle mass and PCSA, did not differ between groups (SOL: 21.2 ± 2.8 N/g and 22.4 ± 3.1 N/cm 2 [SEMA], 20.8 ± 2.4 N/g and 21.7 ± 2.5 N/cm 2 [CR], 19.7 ± 3.5 N/g and 20.4 ± 3.7 N/cm 2 [CON]; EDL: 22.8 ± 2.2 N/g and 17.0 ± 2.0 N/cm 2 [SEMA], 24.5 ± 2.5 N/g and 18.2 ± 2.0 N/cm 2 [CR], 22.9 ± 2.1 N/g and 16.8 ± 1.8 N/cm 2 [CON]). Muscle contraction and relaxation kinetics as well as stretched induced hysteresis and relaxation were similar across groups.

Conclusions

In obese mice, semaglutide induces greater weight loss but similar muscle loss than energy‐matched caloric restriction, while improving aerobic endurance without compromising skeletal muscle function.

Förderung

  • Lietuvos Mokslo Taryba

Zitieren

APA

Minderis, P., Cesanelli, L., Sviderskis, M., Venckunas, T., Gray, S. R., & Ratkevicius, A. (2026). Semaglutide‐Induced Weight Loss Does Not Impair Muscle Function and Improves Endurance Running Capacity in Obese Mice. Journal of Cachexia, Sarcopenia and Muscle, 17(6). https://doi.org/10.1002/jcsm.70427

Vancouver

Minderis P, Cesanelli L, Sviderskis M, Venckunas T, Gray SR, Ratkevicius A. Semaglutide‐Induced Weight Loss Does Not Impair Muscle Function and Improves Endurance Running Capacity in Obese Mice. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(6). doi:10.1002/jcsm.70427

BibTeX
@article{Minderis2026,
  author = {Minderis, Petras and Cesanelli, Leonardo and Sviderskis, Mazvydas and Venckunas, Tomas and Gray, Stuart R. and Ratkevicius, Aivaras},
  title = {Semaglutide‐Induced Weight Loss Does Not Impair Muscle Function and Improves Endurance Running Capacity in Obese Mice},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2026},
  volume = {17},
  number = {6},
  doi = {10.1002/jcsm.70427}
}
Kostenlos starten →